Valo Therapeutics develops a novel virus-based cancer immunotherapy – Medical Xpress
|
Valo Therapeutics develops a novel virus-based cancer immunotherapy
Medical Xpress A spin-out from the University of Helsinki, Valo Therapeutics is developing novel oncolytic viral vaccines for the treatment of multiple forms of cancer. The therapeutic platform is projected to target cancer by recruiting the body's own defense … |
